STOCK TITAN

Sensient Technology Corporation Form 4 Filings

SXT NYSE

Every Form 4 that Sensient Technology Corporation (SXT) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow SXT and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full SXT filings page.

Rhea-AI Summary

Sensient Technologies Corp director Mario Ferruzzi reported selling 1,200 shares of Common Stock on 2026-08-05 at $129.4767 per share in an open-market or private transaction. After this sale, he directly held 7,352.467 common shares (including restricted and dividend reinvestment shares), 3,379.854 deferred stock units that convert 1-for-1 into common stock and are issued upon his termination as director, and 227.311 common shares held indirectly through his spouse’s ESOP.

Rhea-AI Summary

Director Joseph Carleone was credited with 296.253 shares of Deferred Stock, representing a grant or award tied to the deferral of director fees under Sensient Technologies’ Directors' Deferred Compensation Plan. This deferred stock converts into common stock on a one-for-one basis, with shares of common stock to be issued when his board service ends. Following these entries, he holds 24,163.893 shares of common stock directly, including restricted stock under the 2017 Stock Plan and shares accumulated through a dividend reinvestment plan.

Rhea-AI Summary

Sensient Technologies director Mario Ferruzzi reported an award of 44.854 shares of deferred stock for director fees, which converts to common stock on a one-for-one basis. After this award, he holds 3,379.854 deferred stock shares, 8,552.467 common shares directly, and 228.012 common shares indirectly through his spouse's ESOP and dividend reinvestment and stock plans.

Rhea-AI Summary

Sensient Technologies VP, Asia Pacific Group Thierry Hoang sold shares and reported performance stock units. On May 18, 2026, Hoang completed an open-market sale of 400 shares of Common Stock at $115.1895 per share, and held 13,909 shares directly afterward.

The filing also lists three grants of performance stock units, each representing a contingent right to receive one share of Common Stock at target levels of 1,429, 1,610, and 1,925 underlying shares. These awards may vest over three-year performance periods based on EBITDA growth, return on invested capital, revenue, and continued employment, with actual shares earned potentially ranging from 0% to 200% of target amounts depending on performance.

Rhea-AI Summary

Sensient Technologies executive Thierry Hoang, VP Asia Pacific Group, reported an open-market sale of 439 shares of common stock at $114.1514 per share. After this sale, Hoang directly holds 14,309 common shares.

The filing also shows three grants of performance stock units, each representing a contingent right to one common share. Target underlying shares are 1,429 for the 2024–2026 period and 1,610 for the 2025–2027 period, both tied 70% to EBITDA growth and 30% to return on invested capital. A further grant covering 2026–2028 is based on revenue and return on invested capital. Actual shares earned for these awards can range from 0% to 200% of the target amount depending on performance and continued employment.

Rhea-AI Summary

Sensient Technologies executive Steven B. Morris, President of the Color Group, reported an open-market sale of 200 shares of common stock at an average price of $114.5758 per share. After this sale, he directly holds 6,759.372 shares of common stock and indirectly holds 1,175.82 shares through the company ESOP.

In addition, Morris holds several grants of performance stock units, each representing a contingent right to receive one share of common stock. These awards cover 2,641, 2,683, and 2,962 underlying shares at target levels, with three-year performance periods tied to EBITDA growth, revenue, and return on invested capital.

Rhea-AI Summary

Sensient Technologies Corp reported a large insider transaction involving a major shareholder entity. On April 30, 2026, Winder Pte. Ltd., a ten percent owner of Sensient, executed an open-market sale of 2,127,566 shares of common stock at $109.69 per share, in an indirect ownership capacity.

Following this sale, Winder Pte. Ltd. is shown holding 4,177,348 shares of Sensient common stock. The filing explains that these securities are directly held by Winder Pte. Ltd., which is wholly owned through a chain of entities including Winder Investment Anstalt, Winder Anstalt, and ultimately Haldor Foundation; those upstream entities each disclaim beneficial ownership of the shares held by Winder except for their pecuniary interest.

Rhea-AI Summary

Sensient Technologies director Donald W. Landry reported routine equity compensation activity. He received a grant of 1,119 shares of restricted common stock under the company’s 2017 Stock Plan and had 674 shares withheld to cover tax obligations upon vesting of a prior restricted stock grant.

After these transactions, he directly holds 10,447.331 shares of common stock, including restricted shares under the 2017 Stock Plan and shares held in a dividend reinvestment plan. The filing shows compensation- and tax-related movements rather than open-market buying or selling.

Rhea-AI Summary

Sensient Technologies Corp director Brett W. Bruggeman reported routine equity compensation and related tax withholding. He received a grant of 1,119 shares of Common Stock as restricted stock under the company’s 2017 Stock Plan, as amended and restated.

In connection with the vesting of a prior restricted stock grant, 283 shares of Common Stock were withheld to cover tax obligations at an indicated price of $99.23 per share. After these transactions, he directly holds 3,565.542 shares of Sensient common stock, including restricted shares and shares in a dividend reinvestment plan.

Rhea-AI Summary

Sensient Technologies director Joseph Carleone reported an equity compensation grant and updated holdings. On April 23, 2026, he received 1,119 shares of Common Stock as a grant of restricted stock under the issuer’s 2017 Stock Plan at a stated price of $0.0000 per share.

After this award, Carleone directly owns 23,670.313 shares of Common Stock, which include restricted shares and shares in a dividend reinvestment plan. He also holds Deferred Stock linked to 23,780.400 underlying shares of Common Stock, which convert one-for-one and will be issued when his board service ends.

Rhea-AI Summary

Sensient Technologies director Mario Ferruzzi reported routine equity compensation and related tax withholding. On April 23, 2026, he received 1,119 shares of common stock as a restricted stock grant under the company’s 2017 Stock Plan, increasing his directly held common shares to 9,195.186, which include restricted stock and dividend reinvestment plan shares. On the same date, 674 common shares were withheld at $99.23 per share to cover tax obligations from a prior restricted stock vesting, a non-market disposition.

Ferruzzi also reports 227.665 common shares held indirectly through his spouse’s ESOP account and 3,322.810 deferred stock units that convert to common stock on a one-for-one basis, with shares to be issued when his service as a director ends.

Rhea-AI Summary

Sensient Technologies director Carol R. Jackson reported compensation-related stock transactions involving company common stock. On April 23, 2026, she received a grant of 1,119 shares of restricted stock under Sensient's 2017 Stock Plan, as amended and restated.

On the same date, 674 shares were withheld to cover tax obligations tied to the vesting of a prior restricted stock grant, a non‑market, tax-withholding disposition. After these entries, Jackson directly held 6,539.958 shares, including restricted stock and shares in a dividend reinvestment plan.

Rhea-AI Summary

Jain Sharad P reported acquisition or exercise transactions in this Form 4 filing.

Sensient Technologies director Sharad P. Jain received 1,119 shares of common stock as a restricted stock grant under the company’s 2017 Stock Plan. This award was made at no cash cost to Jain and increased his direct holdings to 6,997.266 shares, including restricted shares and dividend reinvestment plan shares.

Rhea-AI Summary

Sensient Technologies director Scott C. Morrison reported routine equity compensation activity. He received a grant of 1,119 shares of common stock as restricted stock under the company’s 2017 Stock Plan at no cash cost. In a separate move, 674 shares were withheld to cover tax obligations tied to the vesting of an earlier restricted stock grant, which is not an open-market sale. After these transactions, he directly holds about 12,220 shares of Sensient common stock, including restricted shares and shares held in a dividend reinvestment plan.

Rhea-AI Summary

Sensient Technologies director Essie Whitelaw reported routine equity compensation activity. She received a grant of 1,119 shares of Common Stock as restricted stock under the company’s 2017 Stock Plan, at a stated price of $0.0000 per share. In connection with the vesting of a prior restricted stock grant, 674 shares of Common Stock were withheld at $99.23 per share to cover tax obligations rather than sold on the open market. After these transactions, she directly holds 17,584.136 shares of Common Stock, which include restricted shares and shares in a dividend reinvestment plan. She also holds deferred stock convertible into 885.666 Common Stock shares on a one-for-one basis, to be issued when her board service ends.

Rhea-AI Summary

Sensient Technologies director Joseph Carleone received 422.547 shares of deferred stock as a grant tied to director fee deferrals. This deferred stock converts into common stock on a one-for-one basis and is issued after his service as a director ends.

Following the grant, his reported deferred stock holdings total 23,780.400 shares. A separate holding entry shows 22,551.313 shares of common stock held directly, which includes restricted stock under the company’s 2017 Stock Plan and shares accumulated through a dividend reinvestment plan.

Rhea-AI Summary

Sensient Technologies director Mario Ferruzzi received a grant of 63.975 units of Deferred Stock as compensation. The deferred stock converts to common stock on a one-for-one basis and represents deferral of director fees under the company’s Directors' Deferred Compensation Plan.

After this award, Ferruzzi holds 3,322.810 deferred stock units and 8,076.186 shares of common stock directly, including restricted stock and shares in a dividend reinvestment plan, plus 227.665 common shares held indirectly through his spouse’s ESOP account.

Rhea-AI Summary

Sensient Technologies executive Steven B. Morris reported a small share disposition linked to taxes and new performance-based equity awards. On March 2, 2026, 373 shares of common stock were withheld at $100.58 per share to cover tax obligations from a prior restricted stock vesting, leaving 6,959.372 directly held shares and additional shares in an ESOP. Morris also holds and received grants of performance stock units that may convert into common stock after three-year performance periods ending in 2026, 2027, and 2028, based on EBITDA growth, revenue, and return on invested capital, with actual shares earned ranging from 0% to 200% of target awards.

Rhea-AI Summary

Sensient Technologies VP, Controller, and CAO Adam Vanderleest reported that 133 shares of common stock were withheld on March 2, 2026 at $100.58 per share to cover taxes on a prior restricted stock vesting, leaving 2,066 directly held shares. He also reports direct holdings of performance stock units that may vest over three-year periods based on EBITDA growth, revenue, and return-on-invested-capital goals, plus 341.255 indirectly held ESOP shares.

Rhea-AI Summary

Sensient Technologies officer Michael C. Geraghty reported equity award activity. On February 12, 2026, 4,924 performance stock units vested at 85.4% of the target award and converted into the same number of shares of common stock at $0 exercise price. To cover taxes from this vesting, 2,462 shares of common stock were withheld at $97.93 per share. After these transactions, he directly owned 45,220.541 common shares, plus 414.308 shares in a Supplemental Benefit Plan and 713.47 shares in an ESOP. He also holds performance stock unit awards covering 5,126, 6,055, and 7,205 shares at target, which may vest over three-year periods based on revenue, EBITDA growth, and return on invested capital performance criteria.

Rhea-AI Summary

Sensient Technologies VP Asia Pacific Group Thierry Hoang reported the vesting and conversion of 1,293 performance stock units into 1,293 shares of common stock on February 12, 2026 at $0 per share through an exercise of a derivative security. Following this transaction, he directly owned 14,748 shares of common stock.

The vested units represented 85.4% of the target award, earned over a three-year period based on adjusted EBITDA growth and adjusted return on invested capital. Hoang also holds additional performance stock unit awards at target levels of 1,429, 1,610, and 1,925 units, which are eligible to vest over separate three-year performance periods ending in 2026, 2027, and 2028 if revenue, EBITDA growth, and return on invested capital goals and continued employment conditions are met. Each unit represents a contingent right to receive one share of common stock, with actual shares earned ranging from 0% to 200% of target depending on performance, subject to specified minimum thresholds.

Rhea-AI Summary

Sensient Technologies VP, HR and Senior Counsel Amy Schmidt Jones reported equity award activity in company stock. On February 12, 2026, she converted 3,388 performance stock units into the same number of common shares at an exercise price of $0, raising her direct common stock holdings to 27,358 shares.

On the same date, 1,694 common shares were disposed of at $97.93 per share to satisfy tax withholding tied to the vesting, leaving her with 25,664 directly held shares. The vested units reflected 85.4% of the target award based on multi‑year adjusted EBITDA and return on invested capital performance. Jones also has indirect ownership of 312.687 common shares through the company ESOP and continues to hold multiple tranches of unvested performance stock units that may vest between 2026 and 2028 depending on EBITDA, revenue, and return on invested capital goals.

Rhea-AI Summary

Sensient Technologies senior vice president, general counsel and secretary John J. Manning reported equity compensation activity involving performance stock units and common shares on February 12, 2026. A block of 4,016 performance stock units vested at 85.4% of the target award and was converted into the same number of shares of common stock at $0 per share. To cover tax withholding related to this vesting, 2,008 common shares were disposed of at $97.93 per share, leaving him with 35,200.467 directly held common shares. He also has indirect beneficial ownership of additional common shares through his children, the company ESOP, and a supplemental benefit plan, and continues to hold several grants of performance stock units that may vest over future three‑year performance periods based on EBITDA growth, revenue and return on invested capital.

Rhea-AI Summary

Sensient Technologies’ Chairman, President & CEO Paul Manning reported equity award activity on February 12, 2026. A block of 30,027 performance stock units vested at 85.4% of the target award and converted into an equal number of common shares at an exercise price of $0.

To cover tax withholding on this vesting, 15,013 common shares were withheld at $97.93 per share. After these transactions, Manning directly owned 275,954 common shares, plus indirect holdings of common stock through his children, the company’s ESOP, and a supplemental benefit plan.

He also continued to hold performance stock units that are eligible to vest after separate three-year performance periods, covering 42,442, 34,492, and 29,516 target shares. Vesting of these units depends on future achievement of performance criteria tied to adjusted EBITDA or revenue growth and return on invested capital.

Rhea-AI Summary

Sensient Technologies’ VP and Chief Financial Officer, Tobin Tornehl, reported equity compensation activity involving performance stock units and common shares. On February 12, 2026, 1,502 performance stock units vested at 85.4% of the target award and converted into 1,502 shares of common stock at an exercise price of $0.

To cover taxes on this vesting, 751 common shares were withheld at $97.93 per share as a tax-withholding disposition, leaving 15,504 common shares held directly. Tornehl also has 959.278 common shares held indirectly through the company ESOP and continues to hold multiple tranches of performance stock units, with target amounts of 3,341, 3,833, and 4,350 units tied to multi-year performance goals based on EBITDA growth, revenue, and return on invested capital, each capable of paying out between 0% and 200% of target depending on results.

Rhea-AI Summary

Sensient Technologies Corp. director Form 4 shows a routine fee deferral into stock-based compensation. On 12/31/2025, the director elected to defer fees under the company’s Directors’ Deferred Compensation Plan, receiving 388.771 units of deferred stock that convert into common shares on a one-for-one basis.

After this transaction, the director beneficially owns 22,484.448 shares of common stock directly and 23,263.025 derivative securities classified as deferred stock. The filing explains that common shares from the deferred stock will be issued when the director’s board service ends, and current holdings also include restricted stock under the 2017 Stock Plan and shares held through a dividend reinvestment plan.

Rhea-AI Summary

Sensient Technologies Corp. director Dr. Ferruzzi reported equity holdings and a new deferred stock award. On 12/31/2025, the director acquired 58.861 shares of deferred stock, which convert to common stock on a one-for-one basis under the company’s Directors’ Deferred Compensation Plan. Following the reported transactions, the director beneficially owns 8,043.478 shares of common stock directly and 227.421 shares indirectly through a spouse’s ESOP account. Some of the directly held shares are restricted stock under the 2017 Stock Plan and shares in a dividend reinvestment plan. The deferred stock will result in common shares being issued when the director’s service with the company ends.

Rhea-AI Summary

Sensient Technologies Corp. director reports deferred stock transaction

A director of Sensient Technologies Corp. (SXT) reported a routine equity-related transaction. On 12/31/2025, the director acquired 102.821 shares of deferred stock through the deferral of director fees under the company’s Directors' Deferred Compensation Plan. This deferred stock is convertible into common stock on a one-for-one basis, with shares of common stock to be issued when the director’s board service ends.

Following this transaction, the director beneficially owned 16,394.007 shares of common stock directly and 5,702.328 derivative securities in the form of deferred stock. The filing identifies the reporting person as a director and indicates the ownership is held directly.

Rhea-AI Summary

Sensient Technologies Corp reported that its Color Group president received new equity awards in the form of restricted stock and performance stock units. On December 17, 2025, he was granted 3,418 shares of common stock at a price of $0 under the company’s 2017 Stock Plan; these shares are restricted for three years following the grant date.

He also acquired 5,126 performance stock units, each representing a contingent right to one share of common stock. This award is eligible to vest after a three-year performance period from January 1, 2026 through December 31, 2028, based on revenue and return on invested capital. Following the reported transactions, he beneficially owns 42,758.541 shares directly, plus additional shares through a supplemental benefit plan and an ESOP.

The filing also lists earlier performance stock unit grants tied to three-year performance periods ending in 2025, 2026 and 2027. For those prior awards, the number of shares ultimately earned depends on achieving performance criteria based on EBITDA growth and return on invested capital, with potential payouts ranging from 0% to 200% of the target award amount.

Rhea-AI Summary

Sensient Technologies Corp reported new equity awards to its VP, Asia Pacific Group, from a transaction dated December 17, 2025. The officer received 953 restricted stock units of common stock at a price of $0 under the company’s 2017 Stock Plan, as amended and restated, bringing direct beneficial ownership to 13,455 common shares.

Each restricted stock unit represents a contingent right to one share of common stock and vests three years after the grant date. The officer also acquired 1,429 performance stock units, each linked to one share, that are eligible to vest based on revenue and return on invested capital performance over a period from January 1, 2026 through December 31, 2028, with 1,429 shares shown as the target amount and the actual number earned potentially higher or lower. Additional performance stock unit grants of 1,513, 1,925 and 1,610 target shares remain outstanding from earlier awards covering performance periods 2023–2025, 2024–2026 and 2025–2027, tied to EBITDA growth and return on invested capital; for these earlier awards, no units vest below a minimum performance level, and at or above that level the shares earned may range from 0% to 200% of the target amount.

Rhea-AI Summary

Sensient Technologies reported equity awards to a company officer dated 12/17/2025. The officer received 2,278 shares of restricted common stock at a price of $0 and now directly holds 23,970 common shares, plus 311.366 shares held indirectly through the ESOP.

The report also shows a grant of 3,418 performance stock units, each representing a contingent right to one common share, as well as existing PSU awards of 3,947, 4,886 and 3,966 units. These PSU awards are eligible to vest after three-year performance periods ending between December 31, 2025 and December 31, 2028, based on metrics such as revenue, EBITDA growth and return on invested capital. For certain PSU grants, no units vest below a minimum level, and at or above that level the actual shares earned may range from 0% to 200% of the target amount, subject to continued employment and other conditions.

Rhea-AI Summary

Sensient Technologies reported equity awards for its SVP, General Counsel and Secretary, John J. Manning. On December 17, 2025, he was granted 2,796 shares of restricted common stock under the company’s 2017 Stock Plan at a price of $0 per share; these shares are restricted for three years following the grant date.

He also received a new award of 4,195 performance stock units, each representing a contingent right to one share of common stock. This award is eligible to vest after a three-year performance period from January 1, 2026 through December 31, 2028, based on revenue and return on invested capital, and the 4,195 units reflect the target amount, with the actual shares earned depending on performance. Following these transactions, Manning beneficially owns 33,192.467 common shares directly, plus additional indirect holdings through family and company benefit plans.

Rhea-AI Summary

Sensient Technologies Corp. reported new equity awards to its Chairman, President & CEO. On 12/17/2025, the executive received a grant of 19,677 shares of restricted common stock at no cost under the company’s 2017 Stock Plan; these shares are restricted for three years from the grant date.

The filing also reports a new award of 29,516 performance stock units, each representing a contingent right to one share of common stock. This award is eligible to vest after a three-year performance period from January 1, 2026 through December 31, 2028, based on revenue and return on invested capital targets, with the 29,516 shares representing the target amount and the actual payout varying with performance.

Following the reported transactions, the executive beneficially owns 260,940 common shares directly, plus additional indirect holdings through family and company benefit plans, and previously granted performance stock units tied to three-year performance periods based on EBITDA growth and return on invested capital.

Rhea-AI Summary

Sensient Technologies reported equity awards to its Flavors Group President on December 17, 2025. The executive acquired 1,761 shares of common stock as a restricted stock grant at a price of $0, bringing direct ownership to 7,332.368 shares, plus 1,130.864 shares held indirectly through the ESOP.

The report also shows 2,641 performance stock units, each representing one share of common stock, that may vest after a three-year performance period from January 1, 2026 through December 31, 2028 based on revenue and return on invested capital goals. Additional performance stock units tied to three-year periods beginning January 1, 2025 and January 1, 2024 cover 2,683 and 2,962 shares at target levels under the company’s 2017 Stock Plan.

Rhea-AI Summary

Sensient Technologies Corp reported that its VP and Treasurer received new equity awards on 12/17/2025. The officer was granted 414 shares of restricted common stock at a price of $0 under the company’s 2017 Stock Plan, as amended and restated, and these shares are restricted for three years following the grant date. After this grant, the officer beneficially owns 3,413 common shares directly and 224.232 shares indirectly through the issuer’s ESOP as of the end of the month immediately preceding this filing. The officer also received 622 performance stock units, each representing a contingent right to one share of common stock. This award is eligible to vest after a three-year performance period from January 1, 2026 through December 31, 2028, based on performance criteria related to revenue and return on invested capital and other terms and conditions, with 622 shares reflecting the target award and the actual shares earned potentially higher or lower.

Rhea-AI Summary

Sensient Technologies Corp. disclosed that its VP and Chief Financial Officer received equity awards on December 17, 2025. The officer was granted 2,900 shares of restricted common stock at a price of $0 under the company’s 2017 Stock Plan; these shares are restricted for three years after the grant date.

The filing also reports an award of 4,350 performance stock units, each representing a contingent right to one share of common stock, eligible to vest after a three-year performance period from January 1, 2026 through December 31, 2028 based on revenue and return on invested capital. Following the reported transactions, the officer beneficially owns 14,753 common shares directly, plus 955.228 shares through the company ESOP, and holds several performance stock unit awards with target amounts of 3,833, 3,341, and 1,758 shares, which can vest based on multi-year EBITDA growth and return on invested capital performance and continued employment conditions.

Rhea-AI Summary

Sensient Technologies Corp reported new stock-based compensation for its VP, Controller, and CAO on 12/17/2025. The executive acquired 570 shares of common stock as restricted stock under the company’s 2017 Stock Plan, as amended and restated, at a stated price of $0; these shares are restricted for three years following the grant date.

The officer was also granted 854 performance stock units, each representing a contingent right to receive one share of common stock. This award is eligible to vest after a three-year performance period from January 1, 2026 through December 31, 2028 based on revenue and return on invested capital criteria and other terms and conditions. After the reported transactions, the executive beneficially owned 2,199 common shares directly and 340.006 shares through the company ESOP, as well as additional previously granted performance stock unit awards tied to multi-year EBITDA growth and return on invested capital goals.

Rhea-AI Summary

Sensient Technologies (SXT) reported equity transactions by its VP and Chief Financial Officer. On 12/08/2025, 586 shares of common stock were disposed of at $90.02 per share to cover tax withholding related to a prior restricted stock vesting, leaving 11,853 shares held directly and 955.228 shares held through the company ESOP as of the prior month-end.

The executive also holds several performance stock unit awards: 3,833, 3,341, and 1,758 units, each representing a contingent right to one share of common stock. These grants under the 2017 Stock Plan are eligible to vest over three-year performance periods tied 70% to EBITDA growth and 30% to return on invested capital, with actual shares earned ranging from 0% to 200% of target based on performance and continued employment conditions.

Rhea-AI Summary

Sensient Technologies reported an insider equity update for its Chairman, President & CEO, Mr. Manning. On 12/08/2025, 11,720 shares of common stock were withheld at $90.02 per share to cover taxes tied to the vesting of a prior restricted stock grant. After this, he directly owned 241,263 common shares, with additional indirect holdings of 80 shares by his children, 893.505 shares in the ESOP, and 3,207.718 shares in the Supplemental Benefit Plan.

The filing also lists outstanding performance stock units, each representing a contingent right to one common share: 35,160, 42,442, and 34,492 units tied to three performance periods running from 2023–2025, 2024–2026, and 2025–2027. For each grant, 70% of the award depends on EBITDA growth and 30% on return on invested capital, with actual vesting outcomes ranging from 0% to 200% of target, subject to performance and continued employment.

Rhea-AI Summary

Sensient Technologies senior vice president, general counsel and secretary John J. Manning reported an insider equity transaction. On 12/08/2025, 1,567 shares of common stock were withheld at $90.02 per share to cover taxes on a prior restricted stock vesting, leaving 30,396.467 shares held directly. He also reports indirect holdings of 49.1 shares held by children, 559.511 shares in the company ESOP, and 507.469 shares in a Supplemental Benefit Plan.

Manning holds performance stock units (PSUs) tied to company performance: 4,791 PSUs for a period from January 1, 2025 through December 31, 2027, 5,824 PSUs for January 1, 2024 through December 31, 2026, and 4,702 PSUs for January 1, 2023 through December 31, 2025. Each PSU represents a right to receive one share, with 70% based on EBITDA growth and 30% on return on invested capital, and the actual shares earned can range from 0% to 200% of target, subject to performance and continued employment.

Rhea-AI Summary

Sensient Technologies Corp. executive reports equity transactions and new performance awards. A company officer, listed as VP, HR and Senior Counsel, reported that 1,322 shares of common stock were disposed of on 12/08/2025 at a price of $90.02, with the explanation that shares were withheld to cover tax obligations upon vesting of a prior restricted stock grant. After this, the officer beneficially owned 21,692 shares directly and 311.366 shares indirectly through the company ESOP.

The filing also reports grants of performance stock units covering 3,966, 4,886, and 3,947 underlying shares of common stock at target levels under the 2017 Stock Plan. Each award has a three-year performance period, with 70% tied to EBITDA growth and 30% tied to return on invested capital. Actual shares earned will depend on performance and continued employment and may range from 0% to 200% of the target award amount, with no vesting below minimum performance levels.

Rhea-AI Summary

Sensient Technologies Corp. executive equity activity: On 12/08/2025, the President of the Color Group reported equity transactions in company stock. A total of 1,921 shares of common stock were withheld at a price of $90.02 per share to cover taxes tied to the vesting of a prior restricted stock grant. After this, the executive beneficially owned 39,340.541 common shares directly, plus 412.559 shares in a Supplemental Benefit Plan and 710.457 shares in an ESOP.

The filing also reports performance stock units (PSUs) covering 6,055, 7,205 and 5,765 shares of common stock. These PSUs were granted under the company’s 2017 Stock Plan and are eligible to vest over three-year performance periods running from 2023–2025, 2024–2026 and 2025–2027. For each grant, 70% of the target award depends on EBITDA growth and 30% on return on invested capital, with potential payout ranging from 0% to 200% of the target shares, subject to continued employment and certain accelerated vesting conditions.

Rhea-AI Summary

Sensient Technologies Corporation reported insider activity by a director on a Form 4. The director sold common stock in two transactions: 533.39 shares at $93.2222 on 11/20/2025 and 3,985 shares at $95.0211 on 12/03/2025, both marked as dispositions. After these sales, the director beneficially owned 17,127.953 shares of common stock, which include restricted stock and shares held in a dividend reinvestment plan. The filing also discloses 878.305 deferred stock units that convert to common stock on a one-for-one basis, with shares issuable when the director’s board service ends.

Rhea-AI Summary

Sensient Technologies (SXT) reported an insider share purchase by its VP and Treasurer. On 11/04/2025, the officer acquired 2,150 shares at $92.98 per share (Transaction Code: P). Following the transaction, the officer beneficially owned 2,999 shares directly, and 224.268 shares indirectly through the ESOP, stated as of the end of the month immediately preceding the filing. Footnotes indicate the direct holdings include restricted stock under the 2017 Stock Plan, as amended and restated.

Rhea-AI Summary

Sensient Technologies (SXT) Form 4: A director reported an open‑market purchase of 1,000 shares of Common Stock on 11/03/2025 at a price of $91.2575 per share (Code P). Following this transaction, the director beneficially owns 22,414.266 shares directly. The filing also lists 22,776.623 deferred stock units, which convert to Common Stock on a one‑for‑one basis, with shares issued upon the director’s termination of service.

Rhea-AI Summary

Dr. Joseph Carleone, a director of Sensient Technologies Corp. (SXT), reported transactions dated 09/30/2025 on Form 4. The filing shows a disposition of 21,414.266 shares of common stock and the acquisition by deferral of 389.185 deferred stock that converts one-for-one into common shares. After these entries the report lists 22,776.623 shares of common stock beneficially owned on a direct basis. The filing states the disposed shares include restricted stock and dividend reinvestment plan holdings, and the deferred shares result from deferral of director fees under the company’s directors’ deferred compensation plan. The signature was filed by an attorney-in-fact on behalf of Dr. Carleone.

Rhea-AI Summary

Insider transaction summary for Sensient Technologies (SXT): On 09/30/2025 director Deborah McKeithan Gebhardt reported changes in her beneficial ownership. The filing records a disposition of 16,332.571 shares of common stock and the acquisition by deferral of 87.187 units of deferred stock under the directors' deferred compensation plan. Deferred stock converts one-for-one into common shares and those 87.187 shares will be issued when her director service ends. The Form 4 was signed on 10/01/2025 by an attorney-in-fact. All items reflect director fee deferrals, restricted stock, and shares held in a dividend reinvestment plan as described in the explanations.